MAPT and Alzheimer disease: Thus one cannot conclude from these results alone that our method of connected language analysis would be a sensitive tool for detecting decline in persons with known preclinical AD, which in research can now be characterized by the presence of beta-amyloid, tau protein accumulation, and neurodegeneration, evidenced by PET-imaging, cerebrospinal fluid analysis, and MRI (Jack et al., 2016).